Several health systems in the U.S., including Northwestern Medicine in Chicago, are participating in a clinical trial for the Aletta device from Vitestro, which automates blood collection. The device aims to enhance the blood draw process by improving efficiency and decreasing patient discomfort. Utilizing infrared light and AI technology, Aletta precisely locates veins and performs blood draws in about two minutes without patient visibility of the needle insertion. This innovation may help mitigate the ongoing shortage of phlebotomists and streamline the overall procedure.
The Aletta device promises to revolutionize blood draws by ensuring high accuracy with low discomfort, essential in addressing the critical shortage of trained phlebotomists.
Patients will only see the robotic system at work rather than witness the needle insertion, which significantly reduces anxiety and fear associated with traditional blood draws.
The automation offered by Aletta not only enhances the efficiency of blood collection but might also alleviate the over-reliance on trained professionals in a challenging healthcare climate.
Each blood draw procedure conducted by Aletta is streamlined to take approximately two minutes, drastically reducing the time and effort usually involved in traditional methods.
Collection
[
|
...
]